Table 2 ANOVA: Comparison of means between dysfunctional BC survivors, functional BC survivors and healthy controls
Group(n)/ Parameter | Dysf BCs (n = 19) Mean ± SD | Funct BCs (n = 13) Mean ± SD | Controls (n = 36) Mean ± SD | p-value (Dysf. vs. control) (Funct. vs. control) (Dysf. vs. funct) |
|---|---|---|---|---|
mREE | 1506 ± 174 | 1372 ± 116 | 1422 ± 153 | 0.049* |
0.115 (Dysf. vs. control) | ||||
0.531 (Funct. vs. control) | ||||
0.026* (Dysf. vs. funct) | ||||
mREE/FFM | 32 ± 3 | 33 ± 3 | 31 ± 3 | 0.080 |
0.213 (Dysf. vs. control) | ||||
0.084 (Funct. vs. control) 0.576 (Dysf. vs. funct) | ||||
mREE/FFMi | 92 ± 8 | 92 ± 8 | 87 ± 10 | 0.098 |
0.120 (Dysf. vs. control) | ||||
0.129 (Funct. vs. control) | ||||
0.995 (Dysf. vs. funct) | ||||
Body weight (kg) | 77.2 ± 14.9 | 61.6 ± 9.2 | 70.4 ± 13.8 | 0.008* |
0.145 (Dysf. vs. control) | ||||
0.090 (Funct. vs. control) | ||||
0.002* (Dysf. vs. funct) | ||||
Body composition | ||||
FM (kg) | 31.4 ± 10.7 | 20.1 ± 6.8 | 26.0 ± 13.7 | 0.040* |
0.259 (Dysf. vs. control) | ||||
0. 209 (Funct. vs. control) | ||||
0.002* (Dysf. vs. funct) | ||||
FM (%) | 37.9 ± 8.8 | 31.7 ± 6.6 | 33.3 ± 8.5 | 0.081 |
0.115 (Dysf. vs. control) | ||||
0.769 (Funct. vs. control) | ||||
0.044* (Dysf. vs. funct) | ||||
FMi (FM/m2) | 18.3 ± 6.2 | 11.9 ± 4.1 | 15.4 ± 7.9 | 0.041* |
0.265 (Dysf. vs. control) | ||||
0.210 (Funct. vs. control) | ||||
0.003* (Dysf. vs. funct) | ||||
FFM (kg) | 46.8 ± 6.1 | 41.8 ± 4.2 | 46.1 ± 5.4 | 0.029* |
0.884 (Dysf. vs. control) | ||||
0.033* (Funct. vs. control) | ||||
FFM (%) | 61.7 ± 8.1 | 65.1 ± 12.9 | 65.1 ± 11.8 | 0.013* (Dysf. vs. funct) |
0.548 | ||||
0.495 (Dysf. vs. control) | ||||
1.000 (Funct. vs. control) | ||||
FFMi (FFM/m2) | 16.4 ± 1.9 | 15.0 ± 1.0 | 16.4 ± 1.5 | 0.382 (Dysf. vs. funct) |
0.013* | ||||
1.000 (Dysf. vs. control) | ||||
0.010 (Funct. vs. control) | ||||
0.008* (Dysf. vs. funct) |